Killer cell immunoglobulin-like receptors (KIRs) are important receptors for regulating the killing of virus-infected or cancer cells of natural killer (NK) cells. KIR2DS2 can recognize peptides derived from hepatitis C virus (HCV) or global flaviviruses (such as dengue and Zika) presented by HLA-C*0102 to activate NK cells, and have shown promising results when used for cancer immunotherapy. Here, we present the complex structure of KIR2DS2 with HLA-C*0102 at a resolution of 2.5Å. Our structure reveals that KIR2DS2 can bind HLA-C*0102 and HLA-A*1101 in two different directions. Moreover, Tyr45 (in activating receptor KIR2DS2) and Phe45 (in inhibitory KIRs) distinguish the two different binding models and binding affinity between activating KIRs and inhibitory KIRs. The conserved “AT” motif of the peptide mediates recognition and determines the peptide specificity of recognition. These structural characteristic shed light on how KIRs activate NK cells and can provide a molecular basis for immunotherapy by NK cells.This article is protected by copyright. All rights reserved.
About The Expert
Alex J Brown